People: Tornier NV (TRNX.O)

TRNX.O on Nasdaq

21.62USD
29 Aug 2014
Price Change (% chg)

$0.35 (+1.65%)
Prev Close
$21.27
Open
$21.30
Day's High
$21.70
Day's Low
$21.22
Volume
91,759
Avg. Vol
238,096
52-wk High
$24.35
52-wk Low
$15.17

Search Stocks

O'Boyle, Kevin 

Brief Biography

Mr. Kevin C. O'Boyle is Interim Non-Executive Independent Vice Chairman of the Board of Tornier NV. Since December 2010, Mr. O’Boyle is one of Company's directors and has served as a director since June 2010. In November 2012, Mr. O’Boyle was appointed as Interim Vice Chairman. From December 2010 to October 2011, Mr. O’Boyle served as Senior Vice President and Chief Financial Officer of Advanced BioHealing Inc., a medical device company which was acquired by Shire PLC in May 2011, and from June 2011 to May 2012, served as Senior Vice President of Business Operations. From January 2003 until December 2009, Mr. O’Boyle served as the Chief Financial Officer of NuVasive, Inc., a medical device company that completed its initial public offering in May 2004. Prior to that time, Mr. O’Boyle served in various positions during his six years with ChromaVision Medical Systems, Inc., a publicly held medical device company specializing in the oncology market, including as its Chief Financial Officer and Chief Operating Officer. Mr. O’Boyle also held various positions during his seven years with Albert Fisher North America, Inc., a publicly held international food company, including Chief Financial Officer and Senior Vice President of Operations. Mr. O’Boyle currently serves on the board of directors of GenMark Diagnostics, Inc., Zeltiq Aesthetics Inc., and Durata Therapeutics, Inc., all publicly traded companies. Mr. O’Boyle is a Certified Public Accountant and received a Bachelor of Science in Accounting from the Rochester Institute of Technology and completed the Executive Management Program at the University of California Los Angeles, John E. Anderson Graduate Business School.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Sean Carney

--

David Mowry

789,619

Kevin O'Boyle

--

Shawn McCormick

906,603

Terry Rich

1,654,300

Gordon Van Ummersen

--
As Of 29 Dec 2012
Search Stocks